keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CTAP(TFA) (103429-32-9 free base) is a potent, highly selective, and brain-penetrant antagonist of the μ-opioid receptor with IC50 of 3.5 nM. It displays over 1200-fold selectivity over δ opioid (IC50=4500 nM) and somatostatin receptors. CTAP(TFA) (103429-32-9 free base) can be used for the study of L-DOPA-induced dyskinesia (LID)
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 205.00 | |
5 mg | In stock | $ 513.00 | |
10 mg | In stock | $ 743.00 | |
25 mg | In stock | $ 1,150.00 | |
50 mg | In stock | $ 1,550.00 | |
100 mg | In stock | $ 2,080.00 |
Description | CTAP(TFA) (103429-32-9 free base) is a potent, highly selective, and brain-penetrant antagonist of the μ-opioid receptor with IC50 of 3.5 nM. It displays over 1200-fold selectivity over δ opioid (IC50=4500 nM) and somatostatin receptors. CTAP(TFA) (103429-32-9 free base) can be used for the study of L-DOPA-induced dyskinesia (LID) |
Synonyms | CTAP(TFA) |
Molecular Weight | 1218.33 |
Formula | C53H70F3N13O13S2 |
CAS No. | TP2050L |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CTAP(TFA) (103429-32-9 free base) TP2050L Endocrinology/Hormones GPCR/G Protein Neuroscience Opioid Receptor CTAP(TFA) (103429 32 9 free base) 103429-32-9 free base 103429-32-9 CTAP(TFA) (103429329 free base) CTAP(TFA) CTAP(TFA) inhibitor inhibit